Keloidal Granuloma - Causes, Treatment & When to See a Doctor

```html

What is Keloidal Granuloma?

A keloidal granuloma is a benign skin lesion that looks like a keloid (a thick, raised scar) but is actually a type of granulomatous inflammation. These nodules are firm, pink‑to‑red, and may be slightly raised above the surrounding skin. Unlike true keloids, they are not caused by excess collagen deposition after injury; instead, they represent a localized immune reaction that forms a collection of macrophages, multinucleated giant cells, and other inflammatory cells. Keloidal granulomas are most often seen on the face, neck, or areas where the skin has been exposed to irritants, trauma, or infections.<sup>1</sup>

Common Causes

The exact trigger for a keloidal granuloma is often unclear, but several conditions and exposures have been linked to its development. Below are the most frequently reported contributors:

• Foreign body reaction – retained suture material, splinters, tattoo ink, or silicone.
• Cutaneous infections – especially with Mycobacterium marinum, atypical mycobacteria, or cutaneous leishmaniasis.
• Inflammatory dermatoses – such as sarcoidosis or granuloma annulare.
• Acne or folliculitis – chronic inflammation of hair follicles can give rise to granulomatous nodules.
• Skin trauma – piercings, lacerations, or surgical scars that heal poorly.
• Vaccination site reactions – especially with adjuvant‑containing vaccines.
• Drug reactions – rare hypersensitivity to medications like interferon‑beta or TNF‑α inhibitors.
• Dermatologic procedures – laser therapy, chemical peels, or cryotherapy that disturb the dermis.
• Autoimmune diseases – systemic lupus erythematosus or rheumatoid arthritis can occasionally manifest as granulomatous skin lesions.
• Environmental exposure – chronic contact with wood dust, chemicals, or metals.

Identifying the underlying cause helps guide treatment and reduces the chance of recurrence.

Associated Symptoms

Keloidal granulomas are usually painless, but they may be accompanied by a range of other signs:

• Localized itching or mild burning sensation.
• Redness or slight warmth over the nodule.
• Gradual increase in size over weeks to months.
• Occasional discharge of serous or mucoid fluid if the lesion becomes ulcerated.
• Hyperpigmentation or hypopigmentation of the surrounding skin after the lesion resolves.
• In rare cases, pain or tenderness if the granuloma compresses a nerve.

When to See a Doctor

Because a keloidal granuloma can mimic other skin conditions—including malignant tumors—prompt evaluation is essential if you notice:

• Rapid growth (doubling in size within a few weeks).
• Ulceration, bleeding, or drainage that does not resolve.
• Persistent pain, throbbing, or a feeling of pressure.
• Changes in color (e.g., black, deep purple, or dark brown).
• Multiple lesions appearing at once, especially after a new medication or procedure.
• Any lesion that does not improve after 4–6 weeks of home care.

Early assessment helps rule out skin cancer, atypical infections, or other granulomatous diseases that require different management.

Diagnosis

Diagnosis is primarily clinical but often requires additional testing to confirm the granulomatous nature and exclude mimickers.

1. Physical Examination

• Assessment of size, shape, color, and consistency.
• Palpation for firmness and attachment to underlying structures.
• Evaluation of nearby lymph nodes for enlargement.

2. Dermoscopy

A handheld dermoscope can reveal characteristic vascular patterns (linear irregular vessels) and a homogeneous pink‑white background that points toward a granulomatous process.

3. Skin Biopsy

A punch or excisional biopsy is the gold standard. Histology typically shows:

• Collections of epithelioid macrophages and multinucleated giant cells.
• Fibroblasts arranged in a keloid‑like pattern.
• Absence of atypical cells or malignancy.
• Special stains (Ziehl‑Neelsen, PAS) to rule out mycobacterial or fungal infection.

4. Laboratory Tests (when indicated)

• Complete blood count (CBC) and erythrocyte sedimentation rate (ESR) to assess systemic inflammation.
• Serum calcium and ACE levels if sarcoidosis is suspected.
• Cultures or PCR for atypical mycobacteria if an infectious trigger is likely.

5. Imaging (rare)

Ultrasound or MRI may be used when the lesion is deep, large, or potentially involving underlying muscle or joint structures.

Treatment Options

Management depends on the lesion’s size, location, symptoms, and the identified cause. Options range from simple observation to pharmacologic and procedural interventions.

1. Observation

Small, asymptomatic lesions that are not cosmetically concerning can be watched. Many resolve spontaneously within 6–12 months.

2. Topical Therapies

• Intralesional corticosteroids (triamcinolone acetonide 10–40 mg/mL) injected every 4–6 weeks can flatten the granuloma by reducing inflammation and fibroblast activity.<sup>2</sup>
• Topical tacrolimus 0.1 % may help in patients who cannot receive injections.

3. Systemic Medications

• Oral corticosteroids (prednisone 0.5 mg/kg) for short courses if there is extensive inflammation or multiple lesions.
• Antibiotics/antimycobacterial agents (e.g., clarithromycin, doxycycline) when an infectious organism is identified.
• Hydroxychloroquine or methotrexate for granulomas linked to autoimmune disease.<sup>3</sup>

4. Physical Modalities

• Cryotherapy – rapid freezing can reduce lesion size but carries a risk of hypopigmentation.
• Laser therapy – pulsed dye laser or CO₂ laser can improve texture and color; often combined with steroids.
• Radiation therapy – low‑dose superficial radiation is reserved for recurrent lesions not responding to other measures.

5. Surgical Excision

Complete excision with primary closure is effective for isolated, well‑demarcated nodules. Surgeons often inject triamcinolone into the wound edges to minimize the risk of recurrence.

6. Combination Approaches

The most successful outcomes often involve a multimodal plan—for example, excision followed by intralesional steroids and post‑operative silicone gel sheeting.

7. Home Care & Symptom Relief

• Gentle cleansing with a mild, fragrance‑free cleanser.
• Applying silicone gel or sheets 12–24 hours daily to keep the area hydrated and reduce collagen buildup.
• Avoiding picking, scratching, or applying harsh chemicals.
• Using over‑the‑counter antihistamine creams if itching is bothersome.

Prevention Tips

While not all keloidal granulomas are preventable, several strategies can lower the risk:

• Prompt wound care – keep cuts, abrasions, or piercings clean, use antiseptic dressings, and avoid prolonged irritation.
• Remove foreign material – if a suture or tattoo pigment triggers a reaction, seek early removal.
• Screen for infections – treat skin infections promptly; avoid swimming in contaminated water if you have open wounds.
• Use non‑irritating cosmetics – avoid products containing known sensitizers (e.g., formaldehyde, parabens) on vulnerable skin.
• Protect skin after procedures – follow post‑operative instructions, use silicone dressings, and avoid sun exposure for at least 6 weeks.
• Monitor medication side effects – discuss any new skin changes with your prescribing physician, especially when starting biologics or interferon.
• Maintain good overall health – balanced diet, adequate hydration, and smoking cessation support normal wound healing.

Emergency Warning Signs

Key Take‑aways

• Keloidal granuloma is a benign, granulomatous skin nodule that mimics a keloid scar.
• It can be triggered by trauma, foreign bodies, infections, medications, or underlying systemic disease.
• Diagnosis relies on clinical exam, dermoscopy, and often a skin biopsy.
• Treatment ranges from observation to intralesional steroids, systemic meds, laser, or surgical removal.
• Prompt medical evaluation is crucial for rapid growth, pain, ulceration, or systemic signs.

For personalized advice and an accurate diagnosis, schedule an appointment with a dermatologist or primary‑care physician. Reliable information sources include the Mayo Clinic, CDC, NIH, WHO, and peer‑reviewed dermatology journals.<sup>1‑4</sup>

---

References:
1. Mayo Clinic. “Granuloma.” https://www.mayoclinic.org.
2. Lee, Y. et al. “Intralesional Triamcinolone for Cutaneous Granulomatous Lesions.” *Dermatologic Surgery*, 2021.
3. WHO. “Guidelines for the Management of Skin and Soft Tissue Infections.” 2020.
4. Cleveland Clinic. “Keloids and Hypertrophic Scars.” https://my.clevelandclinic.org. ```